-
1
-
-
84863337843
-
Alzheimer mechanisms and therapeutics strategies
-
Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutics strategies. Cell 148, 1204-1222.
-
(2012)
Cell
, vol.148
, pp. 1204-1222
-
-
Huang, Y.1
Mucke, L.2
-
2
-
-
84873129804
-
-
Cold Spring Harbor Press, Cold Spring Harbor, New York
-
Selkoe DJ, Mandelkow E, Holtzman DM (2012) The Biology of Alzheimer Disease Cold Spring Harbor Press, Cold Spring Harbor, New York, pp. 511.
-
(2012)
The Biology of Alzheimer Disease
, pp. 511
-
-
Selkoe, D.J.1
Mandelkow, E.2
Holtzman, D.M.3
-
3
-
-
0037135111
-
The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
-
DOI 10.1126/science.1072994
-
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. Erratum in: Science 297, 2209. (Pubitemid 34790756)
-
(2002)
Science
, vol.297
, Issue.5580
, pp. 353-356
-
-
Hardy, J.1
Selkoe, D.J.2
-
4
-
-
84857642949
-
The toxic Aβ oligomer and Alzheimer's disease: An emperor in need of clothes
-
Benilova I, Karran E, De Strooper B (2012) The toxic Aβ oligomer and Alzheimer's disease: An emperor in need of clothes. Nat Neurosci 15, 349-357.
-
(2012)
Nat Neurosci
, vol.15
, pp. 349-357
-
-
Benilova, I.1
Karran, E.2
De Strooper, B.3
-
5
-
-
80052266213
-
The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics
-
Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics. Nat Rev Drug Discov 10, 698-712.
-
(2011)
Nat Rev Drug Discov
, vol.10
, pp. 698-712
-
-
Karran, E.1
Mercken, M.2
De Strooper, B.3
-
6
-
-
84862833600
-
Tau in Alzheimer disease and related tauopathies
-
Iqbal K, Liu F, Gong CX, Grundke-Iqbal I (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7, 656-664.
-
(2010)
Curr Alzheimer Res
, vol.7
, pp. 656-664
-
-
Iqbal, K.1
Liu, F.2
Gong, C.X.3
Grundke-Iqbal, I.4
-
7
-
-
84863867694
-
Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets
-
Lee VM, Brunden KR, Hutton M, Trojanowski JQ (2011) Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. Cold Spring Harb Perspect Med 1, a006437.
-
(2011)
Cold Spring Harb Perspect Med
, vol.1
-
-
Lee, V.M.1
Brunden, K.R.2
Hutton, M.3
Trojanowski, J.Q.4
-
8
-
-
85027949706
-
Tau mediated neurodegeneration: An insight into Alzheimer's disease pathology
-
Obulesu M, Venu R, Somashekhar R (2011) Tau mediated neurodegeneration: An insight into Alzheimer's disease pathology. Neurochem Res 36, 1329-1335.
-
(2011)
Neurochem Res
, vol.36
, pp. 1329-1335
-
-
Obulesu, M.1
Venu, R.2
Somashekhar, R.3
-
9
-
-
76849086405
-
The secretases: Enzymes with therapeutic potential in Alzheimer disease
-
De Strooper B, Vassar R, Golde T (2010) The secretases: Enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 6, 99-107.
-
(2010)
Nat Rev Neurol
, vol.6
, pp. 99-107
-
-
De Strooper, B.1
Vassar, R.2
Golde, T.3
-
10
-
-
70350451482
-
Gamma- Secretase: Successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment
-
Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima- Kawashima M, Funamoto S, Ihara Y (2009) gamma- Secretase: Successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci 29, 13042-13052.
-
(2009)
J Neurosci
, vol.29
, pp. 13042-13052
-
-
Takami, M.1
Nagashima, Y.2
Sano, Y.3
Ishihara, S.4
Morishima-Kawashima, M.5
Funamoto, S.6
Ihara, Y.7
-
11
-
-
78651266932
-
Autosomal-dominant Alzheimer's disease: A reviewand proposal for the prevention of Alzheimer's disease
-
Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, Xiong C (2011) Autosomal-dominant Alzheimer's disease: A reviewand proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther 3, 1.
-
(2011)
Alzheimers Res Ther
, vol.3
, pp. 1
-
-
Bateman, R.J.1
Aisen, P.S.2
De Strooper, B.3
Fox, N.C.4
Lemere, C.A.5
Ringman, J.M.6
Salloway, S.7
Sperling, R.A.8
Windisch, M.9
Xiong, C.10
-
12
-
-
77957785420
-
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
-
Kuperstein I, Broersen K, Benilova I, Rozenski J, Jonckheere W, Debulpaep M, Vandersteen A, Segers-Nolten I, Van Der Werf K, Subramaniam V, Braeken D, Callewaert G, Bartic C, D'Hooge R, Martins IC, Rousseau F, Schymkowitz J, De Strooper B (2010) Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J 29, 3408-3420.
-
(2010)
EMBO J
, vol.29
, pp. 3408-3420
-
-
Kuperstein, I.1
Broersen, K.2
Benilova, I.3
Rozenski, J.4
Jonckheere, W.5
Debulpaep, M.6
Vandersteen, A.7
Segers-Nolten, I.8
Van Der Werf, K.9
Subramaniam, V.10
Braeken, D.11
Callewaert, G.12
Bartic, C.13
D'Hooge, R.14
Martins, I.C.15
Rousseau, F.16
Schymkowitz, J.17
De Strooper, B.18
-
13
-
-
22544482926
-
Aβ42 is essential for parenchymal and vascular amyloid deposition in mice
-
DOI 10.1016/j.neuron.2005.06.030, PII S0896627305005362
-
McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, Eckman CB, Dickson DW, Hutton M, Hardy J, Golde T (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199. (Pubitemid 41019251)
-
(2005)
Neuron
, vol.47
, Issue.2
, pp. 191-199
-
-
McGowan, E.1
Pickford, F.2
Kim, J.3
Onstead, L.4
Eriksen, J.5
Yu, C.6
Skipper, L.7
Murphy, M.P.8
Beard, J.9
Das, P.10
Jansen, K.11
DeLucia, M.12
Lin, W.-L.13
Dolios, G.14
Wang, R.15
Eckman, C.B.16
Dickson, D.W.17
Hutton, M.18
Hardy, J.19
Golde, T.20
more..
-
14
-
-
84870333377
-
A chemical route towards Alzheimer's disease?
-
Bettayeb K, Oumata N, Zhang Y, LuoW, Bustos V, Galons H, Greengard P, Meijer L, Flajolet M (2012) A chemical route towards Alzheimer's disease? FASEB J 26, 5115-5123.
-
(2012)
FASEB J
, vol.26
, pp. 5115-5123
-
-
Bettayeb, K.1
Oumata, N.2
Zhang, Y.3
Luow Bustos, V.4
Galons, H.5
Greengard, P.6
Meijer, L.7
Flajolet, M.8
-
15
-
-
34548812551
-
The role of amyloid β peptide 42 in Alzheimer's disease
-
DOI 10.1016/j.pharmthera.2007.06.006, PII S016372580700143X
-
Findeis MA (2007) The role of amyloid beta peptide 42 in Alzheimer's disease. Pharmacol Ther 116, 266-286. (Pubitemid 47451506)
-
(2007)
Pharmacology and Therapeutics
, vol.116
, Issue.2
, pp. 266-286
-
-
Findeis, M.A.1
-
16
-
-
84873681445
-
A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of alzheimer's disease patients and healthy controls
-
Pannee J, Portelius E, Oppermann M, Atkins A, Hornshaw M, Zegers I, Höjrup P, Minthon L, Hansson O, Zetterberg H, Blennow K, Gobom J (2013) A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of alzheimer's disease patients and healthy controls. J Alzheimers Dis 33, 1021- 1032.
-
(2013)
J Alzheimers Dis
, vol.33
, pp. 1021-1032
-
-
Pannee, J.1
Portelius, E.2
Oppermann, M.3
Atkins, A.4
Hornshaw, M.5
Zegers, I.6
Höjrup, P.7
Minthon, L.8
Hansson, O.9
Zetterberg, H.10
Blennow, K.11
Gobom, J.12
-
18
-
-
66249136327
-
Practical synthesis of roscovitine and CR8
-
Oumata N, Ferandin Y, Meijer L, Galons H (2009) Practical synthesis of roscovitine and CR8. Org Process Res Dev 13, 641-644.
-
(2009)
Org Process Res Dev
, vol.13
, pp. 641-644
-
-
Oumata, N.1
Ferandin, Y.2
Meijer, L.3
Galons, H.4
-
19
-
-
33750154346
-
-
World Intellectual Property Organization, Pub. No. WO/2004-110350
-
Cheng S, Comer DD, Mao L, Balow GP, Pleynet D. (2004) compounds and uses thereof in modulating amyloid beta. World Intellectual Property Organization, Pub. No. WO/2004-110350.
-
(2004)
Compounds and Uses Thereof in Modulating Amyloid Beta
-
-
Cheng, S.1
Comer, D.D.2
Mao, L.3
Balow, G.P.4
Pleynet, D.5
-
20
-
-
33744503967
-
Increased cerebrospinal fluid aβ38/aβ42 ratio in alzheimer disease
-
DOI 10.1159/000090363
-
Mehta PD, Pirttila T (2005) Increased cerebrospinal fluid A beta38/A beta42 ratio in Alzheimer disease. Neurodegener Dis 2, 242-245. (Pubitemid 43805907)
-
(2005)
Neurodegenerative Diseases
, vol.2
, Issue.5
, pp. 242-245
-
-
Mehta, P.D.1
Pirttila, T.2
-
21
-
-
0033008720
-
Quantification of sub-femtomole amounts of Alzheimer amyloid β peptides
-
Potempska A, Mack K, Mehta P, Kim KS, Miller DL (1999) Quantification of sub-femtomole amounts of Alzheimer amyloid beta peptides. Amyloid 6, 14-21. (Pubitemid 29249931)
-
(1999)
Amyloid
, vol.6
, Issue.1
, pp. 14-21
-
-
Potempska, A.1
Mack, K.2
Mehta, P.3
Kim, K.S.4
Miller, D.L.5
-
22
-
-
34247187312
-
Regulation of Alzheimer's disease amyloid-β formation by casein kinase I
-
DOI 10.1073/pnas.0611236104
-
Flajolet M, He G, Heiman M, Lin A, Nairn AC, Greengard P (2007) Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I. Proc Natl Acad Sci U S A 104, 4159-4164. (Pubitemid 47181595)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.10
, pp. 4159-4164
-
-
Flajolet, M.1
He, G.2
Heiman, M.3
Lin, A.4
Nairn, A.C.5
Greengard, P.6
-
23
-
-
51849106058
-
Roscovitine-derived, dual-specificity inhibitors of cyclindependent kinases (CDKs) and casein kinase 1 (CK1)
-
Oumata N, Bettayeb K, Ferandin Y, Demange L, Lopez- Giral A, Goddard M-L, Myrianthopoulos V, Mikros E, Flajolet M, Greengard P, Meijer L, Galons H (2008) Roscovitine-derived, dual-specificity inhibitors of cyclindependent kinases (CDKs) and casein kinase 1 (CK1). J Med Chem 51, 5229-5242.
-
(2008)
J Med Chem
, vol.51
, pp. 5229-5242
-
-
Oumata, N.1
Bettayeb, K.2
Ferandin, Y.3
Demange, L.4
Lopez- Giral, A.5
Goddard, M.-L.6
Myrianthopoulos, V.7
Mikros, E.8
Flajolet, M.9
Greengard, P.10
Meijer, L.11
Galons, H.12
-
24
-
-
0037665145
-
Roscovitine and other purines as kinase inhibitors. from starfish oocytes to clinical trials
-
Meijer L, Raymond E (2003) Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Accounts Chem Res 36, 417-425.
-
(2003)
Accounts Chem Res
, vol.36
, pp. 417-425
-
-
Meijer, L.1
Raymond, E.2
-
25
-
-
53249149292
-
CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases
-
Bettayeb K, Oumata N, Echalier A, Ferandin Y, Endicott JA, Galons H, Meijer L (2008) CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene 27, 5797-5807.
-
(2008)
Oncogene
, vol.27
, pp. 5797-5807
-
-
Bettayeb, K.1
Oumata, N.2
Echalier, A.3
Ferandin, Y.4
Endicott, J.A.5
Galons, H.6
Meijer, L.7
-
26
-
-
0035163347
-
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
-
DOI 10.1046/j.1471-4159.2001.00012.x
-
DoveyHF, JohnV, Anderson JP, Chen LZ, de Saint Andrieu P, Fang LY, Freedman SB, Folmer B, Goldbach E, Holsztynska EJ, Hu KL, Johnson-Wood KL, Kennedy SL, Kholodenko D, Knops JE, Latimer LH, Lee M, Liao Z, Lieberburg IM, Motter RN, Mutter LC, Nietz J, Quinn KP, Sacchi KL, Seubert PA, Shopp GM, Thorsett ED, Tung JS, Wu J, Yang S, Yin CT, Schenk DB, May PC, Altstiel LD, Bender MH, Boggs LN, Britton TC, Clemens JC, Czilli DL, Dieckman-McGinty DK, Droste JJ, Fuson KS, Gitter BD, Hyslop PA, Johnstone EM, Li WY, Little SP, Mabry TE, Miller FD, Audia JE (2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76, 173-181. (Pubitemid 32044380)
-
(2001)
Journal of Neurochemistry
, vol.76
, Issue.1
, pp. 173-181
-
-
Dovey, H.F.1
John, V.2
Anderson, J.P.3
Chen, L.Z.4
De Saint Andrieu, P.5
Fang, L.Y.6
Freedman, S.B.7
Folmer, B.8
Goldbach, E.9
Holsztynska, E.J.10
Hu, K.L.11
Johnson-Wood, K.L.12
Kennedy, S.L.13
Kholodenko, D.14
Knops, J.E.15
Latimer, L.H.16
Lee, M.17
Liao, Z.18
Lieberburg, I.M.19
Motter, R.N.20
Mutter, L.C.21
Nietz, J.22
Quinn, K.P.23
Sacchi, K.L.24
Seubert, P.A.25
Shopp, G.M.26
Thorsett, E.D.27
Tung, J.S.28
Wu, J.29
Yang, S.30
Yin, C.T.31
Schenk, D.B.32
May, P.C.33
Altstiel, L.D.34
Bender, M.H.35
Boggs, L.N.36
Britton, T.C.37
Clemens, J.C.38
Czilli, D.L.39
Dieckman-McGinty, D.K.40
Droste, J.J.41
Fuson, K.S.42
Gitter, B.D.43
Hyslop, P.A.44
Johnstone, E.M.45
Li, W.-Y.46
Little, S.P.47
Mabry, T.E.48
Miller, F.D.49
Ni, B.50
Nissen, J.S.51
Porter, W.J.52
Potts, B.D.53
Reel, J.K.54
Stephenson, D.55
Su, Y.56
Shipley, L.A.57
Whitesitt, C.A.58
Yin, T.59
Audia, J.E.60
more..
-
27
-
-
39849092859
-
Identification of gamma-secretase inhibitor potency determinants on presenilin
-
Zhao B, Yu M, Neitzel M, Marugg J, Jagodzinski J, Lee M, Hu K, Schenk D, Yednock T, Basi G (2008) Identification of gamma-secretase inhibitor potency determinants on presenilin. J Biol Chem 283, 2927-2938.
-
(2008)
J Biol Chem
, vol.283
, pp. 2927-2938
-
-
Zhao, B.1
Yu, M.2
Neitzel, M.3
Marugg, J.4
Jagodzinski, J.5
Lee, M.6
Hu, K.7
Schenk, D.8
Yednock, T.9
Basi, G.10
-
28
-
-
77956311201
-
Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease
-
Kounnas MZ, Danks AM, Cheng S, Tyree C, Ackerman E, Zhang X, Ahn K, Nguyen P, Comer D, Mao L, Yu C, Pleynet D, Digregorio PJ, Velicelebi G, Stauderman KA, Comer WT, MobleyWC, Li YM, Sisodia SS, Tanzi RE,Wagner SL (2010) Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease. Neuron 67, 769-780.
-
(2010)
Neuron
, vol.67
, pp. 769-780
-
-
Kounnas, M.Z.1
Danks, A.M.2
Cheng, S.3
Tyree, C.4
Ackerman, E.5
Zhang, X.6
Ahn, K.7
Nguyen, P.8
Comer, D.9
Mao, L.10
Yu, C.11
Pleynet, D.12
Digregorio, P.J.13
Velicelebi, G.14
Stauderman, K.A.15
Comer, W.T.16
Mobley, W.C.17
Li, Y.M.18
Sisodia, S.S.19
Tanzi, R.E.20
Wagner, S.L.21
more..
-
29
-
-
79955426777
-
Attenuated Abeta42 responses to low potency gamma-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds
-
Kretner B, Fukumori A, Gutsmiedl A, Page RM, Luebbers T, Galley G, Baumann K, Haass C, Steiner H (2011) Attenuated Abeta42 responses to low potency gamma-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds. J Biol Chem 286, 15240-15251.
-
(2011)
J Biol Chem
, vol.286
, pp. 15240-15251
-
-
Kretner, B.1
Fukumori, A.2
Gutsmiedl, A.3
Page, R.M.4
Luebbers, T.5
Galley, G.6
Baumann, K.7
Haass, C.8
Steiner, H.9
-
30
-
-
80054801471
-
Novel γ-secretase enzyme modulators directly target presenilin protein
-
Ebke A, Luebbers T, Fukumori A, Shirotani K, Haass C, Baumann K, Steiner H (2011) Novel γ-secretase enzyme modulators directly target presenilin protein. J Biol Chem 286, 37181-37186.
-
(2011)
J Biol Chem
, vol.286
, pp. 37181-37186
-
-
Ebke, A.1
Luebbers, T.2
Fukumori, A.3
Shirotani, K.4
Haass, C.5
Baumann, K.6
Steiner, H.7
-
31
-
-
78650678688
-
Decreased clearance of CNS beta-amyloid in Alzheimer's disease
-
Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330, 1774.
-
(2010)
Science
, vol.330
, pp. 1774
-
-
Mawuenyega, K.G.1
Sigurdson, W.2
Ovod, V.3
Munsell, L.4
Kasten, T.5
Morris, J.C.6
Yarasheski, K.E.7
Bateman, R.J.8
-
32
-
-
80054891306
-
Aβ- degrading enzymes: Potential for treatment of Alzheimer disease
-
Miners JS, Barua N, Kehoe PG, Gill S, Love S (2011) Aβ- degrading enzymes: Potential for treatment of Alzheimer disease. J Neuropathol Exp Neurol 70, 944-959.
-
(2011)
J Neuropathol Exp Neurol
, vol.70
, pp. 944-959
-
-
Miners, J.S.1
Barua, N.2
Kehoe, P.G.3
Gill, S.4
Love, S.5
-
33
-
-
45749114895
-
The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice
-
DOI 10.1172/JCI33585
-
Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, Wyss-Coray T (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118, 2190-2199. (Pubitemid 351872337)
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.6
, pp. 2190-2199
-
-
Pickford, F.1
Masliah, E.2
Britschgi, M.3
Lucin, K.4
Narasimhan, R.5
Jaeger, P.A.6
Small, S.7
Spencer, B.8
Rockenstein, E.9
Levine, B.10
Wyss-Coray, T.11
-
34
-
-
58449101589
-
Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila
-
Ling D, Song HJ, Garza D, Neufeld TP, Salvaterra PM (2009) Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. PLoS One 4, e4201.
-
(2009)
PLoS One
, vol.4
-
-
Ling, D.1
Song, H.J.2
Garza, D.3
Neufeld, T.P.4
Salvaterra, P.M.5
-
35
-
-
77956215864
-
Regulation of amyloid precursor protein processing by the Beclin 1 complex
-
Jaeger PA, Pickford F, Sun CH, Lucin KM, Masliah E,Wyss- Coray T (2010) Regulation of amyloid precursor protein processing by the Beclin 1 complex. PLoS One 5, e11102.
-
(2010)
PLoS One
, vol.5
-
-
Jaeger, P.A.1
Pickford, F.2
Sun, C.H.3
Lucin, K.M.4
Masliah, E.5
Wyss- Coray, T.6
-
36
-
-
79957917512
-
A smallmolecule enhancer of autophagy decreases levels of Abeta and APP-CTF via Atg5-dependent autophagy pathway
-
Tian Y, Bustos V, Flajolet M, Greengard P (2011) A smallmolecule enhancer of autophagy decreases levels of Abeta and APP-CTF via Atg5-dependent autophagy pathway. FASEB J 25, 1934-1942.
-
(2011)
FASEB J
, vol.25
, pp. 1934-1942
-
-
Tian, Y.1
Bustos, V.2
Flajolet, M.3
Greengard, P.4
-
37
-
-
79451471809
-
Brain aging and Aβ1-42 neurotoxicity converge via deterioration in autophagy-lysosomal system: A conditional Drosophila model linking Alzheimer's neurodegeneration with aging
-
Ling D, Salvaterra PM (2011) Brain aging and Aβ1-42 neurotoxicity converge via deterioration in autophagy-lysosomal system: A conditional Drosophila model linking Alzheimer's neurodegeneration with aging. Acta Neuropathol 121, 183- 191.
-
(2011)
Acta Neuropathol
, vol.121
, pp. 183-191
-
-
Ling, D.1
Salvaterra, P.M.2
-
38
-
-
77953913051
-
Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations
-
Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, Nixon RA (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146-1158.
-
(2010)
Cell
, vol.141
, pp. 1146-1158
-
-
Lee, J.H.1
Yu, W.H.2
Kumar, A.3
Lee, S.4
Mohan, P.S.5
Peterhoff, C.M.6
Wolfe, D.M.7
Martinez-Vicente, M.8
Massey, A.C.9
Sovak, G.10
Uchiyama, Y.11
Westaway, D.12
Cuervo, A.M.13
Nixon, R.A.14
-
39
-
-
79955969705
-
Autophagy failure in Alzheimer's disease-locating the primary defect
-
Nixon RA,Yang DS (2011) Autophagy failure in Alzheimer's disease-locating the primary defect. Neurobiol Dis 43, 38-45.
-
(2011)
Neurobiol Dis
, vol.43
, pp. 38-45
-
-
Nixon, R.A.1
Yang, D.S.2
-
40
-
-
79959979604
-
Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis
-
Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, Wesson DW, Bandyopadhyay U, Jiang Y, Pawlik M, Peterhoff CM, Yang AJ, Wilson DA, St George-Hyslop P,WestawayD,Mathews PM,LevyE, Cuervo AM, Nixon RA (2011) Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis. Autophagy 7, 788-789.
-
(2011)
Autophagy
, vol.7
, pp. 788-789
-
-
Yang, D.S.1
Stavrides, P.2
Mohan, P.S.3
Kaushik, S.4
Kumar, A.5
Ohno, M.6
Schmidt, S.D.7
Wesson, D.W.8
Bandyopadhyay, U.9
Jiang, Y.10
Pawlik, M.11
Peterhoff, C.M.12
Yang, A.J.13
Wilson, D.A.14
St George-Hyslop, P.15
Westaway, D.16
Mathews, P.M.17
Levy, E.18
Cuervo, A.M.19
Nixon, R.A.20
more..
-
41
-
-
43049163813
-
Substrate specificity of gammasecretase and other intramembrane proteases
-
Beel AJ, Sanders CR (2008) Substrate specificity of gammasecretase and other intramembrane proteases. Cell Mol Life Sci 65, 1311-1334.
-
(2008)
Cell Mol Life Sci
, vol.65
, pp. 1311-1334
-
-
Beel, A.J.1
Sanders, C.R.2
-
42
-
-
70449523262
-
Analysis of the gamma-secretase interactome and validation of its association with tetraspanin-enriched microdomains
-
Wakabayashi T, Craessaerts K, Bammens L, Bentahir M, Borgions F, Herdewijn P, Staes A, Timmerman E, Vandekerckhove J, Rubinstein E, Boucheix C, Gevaert K, De Strooper B (2009) Analysis of the gamma-secretase interactome and validation of its association with tetraspanin-enriched microdomains. Nat Cell Biol 11, 1340-1346.
-
(2009)
Nat Cell Biol
, vol.11
, pp. 1340-1346
-
-
Wakabayashi, T.1
Craessaerts, K.2
Bammens, L.3
Bentahir, M.4
Borgions, F.5
Herdewijn, P.6
Staes, A.7
Timmerman, E.8
Vandekerckhove, J.9
Rubinstein, E.10
Boucheix, C.11
Gevaert, K.12
De Strooper, B.13
-
43
-
-
84859488864
-
Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain
-
Hur JY, Teranishi Y, Kihara T, Yamamoto NG, Inoue M, HosiaW, HashimotoM,Winblad B, Frykman S, TjernbergLO (2012) Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain. J Biol Chem 287, 11991-12005.
-
(2012)
J Biol Chem
, vol.287
, pp. 11991-12005
-
-
Hur, J.Y.1
Teranishi, Y.2
Kihara, T.3
Yamamoto, N.G.4
Inoue, M.5
Hosia, W.6
Hashimoto, M.7
Winblad, B.8
Frykman, S.9
Tjernberg, L.O.10
-
44
-
-
21044458540
-
Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production
-
DOI 10.1038/nm1235
-
Kukar T, MurphyMP, Eriksen JL, Sagi SA,Weggen S, Smith TE, Ladd T, Khan MA, Kache R, Beard J, Dodson M, Merit S, OzolsVV, Anastasiadis PZ, Das P, Fauq A,Koo EH, Golde TE (2005) Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med 11, 545-550. (Pubitemid 40685978)
-
(2005)
Nature Medicine
, vol.11
, Issue.5
, pp. 545-550
-
-
Kukar, T.1
Murphy, M.P.2
Eriksen, J.L.3
Sagi, S.A.4
Weggen, S.5
Smith, T.E.6
Ladd, T.7
Khan, M.A.8
Kache, R.9
Beard, J.10
Dodson, M.11
Merit, S.12
Ozols, V.V.13
Anastasiadis, P.Z.14
Das, P.15
Fauq, A.16
Koo, E.H.17
Golde, T.E.18
-
45
-
-
38149013121
-
Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation
-
Page RM, Baumann K, Tomioka M, Pérez-Revuelta BI, Fukumori A, Jacobsen H, Flohr A, LuebbersT,OzmenL, Steiner H, Haass C (2008) Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation. J Biol Chem 283, 677-683.
-
(2008)
J Biol Chem
, vol.283
, pp. 677-683
-
-
Page, R.M.1
Baumann, K.2
Tomioka, M.3
Pérez-Revuelta, B.I.4
Fukumori, A.5
Jacobsen, H.6
Flohr, A.7
Luebbers, T.8
Ozmen, L.9
Steiner, H.10
Haass, C.11
-
46
-
-
82455167920
-
Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1
-
Ohki Y, Higo T, Uemura K, Shimada N, Osawa S, Berezovska O, Yokoshima S, Fukuyama T, Tomita T, Iwatsubo T (2011) Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1. EMBO J 30, 4815-4824.
-
(2011)
EMBO J
, vol.30
, pp. 4815-4824
-
-
Ohki, Y.1
Higo, T.2
Uemura, K.3
Shimada, N.4
Osawa, S.5
Berezovska, O.6
Yokoshima, S.7
Fukuyama, T.8
Tomita, T.9
Iwatsubo, T.10
-
47
-
-
82455172862
-
Piperidine acetic acid based γ-secretase modulators directly bind to Presenilin-1
-
Crump CJ, Fish BA, Castro SV, Chau DM, Gertsik N, Ahn K, Stiff C, Pozdnyakov N, Bales KR, Johnson DS, LiYM(2011) Piperidine acetic acid based γ-secretase modulators directly bind to Presenilin-1. ACS Chem Neurosci 2, 705-710.
-
(2011)
ACS Chem Neurosci
, vol.2
, pp. 705-710
-
-
Crump, C.J.1
Fish, B.A.2
Castro, S.V.3
Chau, D.M.4
Gertsik, N.5
Ahn, K.6
Stiff, C.7
Pozdnyakov, N.8
Bales, K.R.9
Johnson, D.S.10
Li, Y.M.11
-
48
-
-
47749107571
-
Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase
-
Czirr E, Cottrell BA, Leuchtenberger S, Kukar T, Ladd TB, Esselmann H, Paul S, Schubenel R, Torpey JW, Pietrzik CU, Golde TE, Wiltfang J, Baumann K, Koo EH, Weggen S (2008) Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase. J Biol Chem 283, 17049- 17054.
-
(2008)
J Biol Chem
, vol.283
, pp. 17049-17054
-
-
Czirr, E.1
Cottrell, B.A.2
Leuchtenberger, S.3
Kukar, T.4
Ladd, T.B.5
Esselmann, H.6
Paul, S.7
Schubenel, R.8
Torpey, J.W.9
Pietrzik, C.U.10
Golde, T.E.11
Wiltfang, J.12
Baumann, K.13
Koo, E.H.14
Weggen, S.15
-
49
-
-
84655164279
-
γ-secretase inhibitors and modulators for Alzheimer's disease
-
Wolfe MS (2012) γ-secretase inhibitors and modulators for Alzheimer's disease. J Neurochem 120(Suppl 1), 89-98.
-
(2012)
J Neurochem
, vol.120
, Issue.SUPPL. 1
, pp. 89-98
-
-
Wolfe, M.S.1
-
50
-
-
79851473226
-
γ-secretase modulators as potential disease modifying anti-Alzheimer's drugs
-
Oehlrich D, Berthelot DJ, Gijsen HJ (2011) γ-secretase modulators as potential disease modifying anti-Alzheimer's drugs. J Med Chem 54, 669-698.
-
(2011)
J Med Chem
, vol.54
, pp. 669-698
-
-
Oehlrich, D.1
Berthelot, D.J.2
Gijsen, H.J.3
-
51
-
-
84859496092
-
First and second generation γ-secretase modulators (GSMs) modulate amyloid-β (Aβ) peptide production through different mechanisms
-
Borgegard T, Juréus A, Olsson F, Rosqvist S, Sabirsh A, Rotticci D, Paulsen K, Klintenberg R, Yan H, Waldman M, Stromberg K, Nord J, Johansson J, Regner A, Parpal S, Malinowsky D, Radesater AC, Li T, Singh R, Eriksson H, Lundkvist J (2012) First and second generation γ-secretase modulators (GSMs) modulate amyloid-β (Aβ) peptide production through different mechanisms. J Biol Chem 87, 11810-11819.
-
(2012)
J Biol Chem
, vol.87
, pp. 11810-11819
-
-
Borgegard, T.1
Juréus, A.2
Olsson, F.3
Rosqvist, S.4
Sabirsh, A.5
Rotticci, D.6
Paulsen, K.7
Klintenberg, R.8
Yan, H.9
Waldman, M.10
Stromberg, K.11
Nord, J.12
Johansson, J.13
Regner, A.14
Parpal, S.15
Malinowsky, D.16
Radesater, A.C.17
Li, T.18
Singh, R.19
Eriksson, H.20
Lundkvist, J.21
more..
-
52
-
-
77957096840
-
Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization
-
Richter L, Munter LM, Ness J, Hildebrand PW, Dasari M, Unterreitmeier S, Bulic B, Beyermann M, Gust R, Reif B, Weggen S, Langosch D, Multhaup G (2010) Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization. Proc Natl Acad Sci U S A 107, 14597-14602.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 14597-14602
-
-
Richter, L.1
Munter, L.M.2
Ness, J.3
Hildebrand, P.W.4
Dasari, M.5
Unterreitmeier, S.6
Bulic, B.7
Beyermann, M.8
Gust, R.9
Reif, B.10
Weggen, S.11
Langosch, D.12
Multhaup, G.13
-
53
-
-
79952079871
-
The amyloid precursor protein C-terminal fragment C100 occurs in monomeric and dimeric stable conformations and binds γ-secretase modulators
-
Botev A, Munter LM, Wenzel R, Richter L, Althoff V, Ismer J, Gerling U, Weise C, Koksch B, Hildebrand PW, Bittl R, MulthaupG(2011) The amyloid precursor protein C-terminal fragment C100 occurs in monomeric and dimeric stable conformations and binds γ-secretase modulators. Biochemistry 50, 828-835.
-
(2011)
Biochemistry
, vol.50
, pp. 828-835
-
-
Botev, A.1
Munter, L.M.2
Wenzel, R.3
Richter, L.4
Althoff, V.5
Ismer, J.6
Gerling, U.7
Weise, C.8
Koksch, B.9
Hildebrand, P.W.10
Bittl, R.11
Multhaup, G.12
-
54
-
-
45149105232
-
Substrate-targeting gamma-secretase modulators
-
Kukar TL, Ladd TB, Bann MA, Fraering PC, Narlawar R, Maharvi GM, Healy B, Chapman R, Welzel AT, Price RW, Moore B, Rangachari V, Cusack B, Eriksen J, Jansen-West K, Verbeeck C, Yager D, Eckman C, Ye W, Sagi S, Cottrell BA, Torpey J, Rosenberry TL, Fauq A, Wolfe MS, Schmidt B,Walsh DM, Koo EH, Golde TE (2008) Substrate-targeting gamma-secretase modulators. Nature 453, 925-929.
-
(2008)
Nature
, vol.453
, pp. 925-929
-
-
Kukar, T.L.1
Ladd, T.B.2
Bann, M.A.3
Fraering, P.C.4
Narlawar, R.5
Maharvi, G.M.6
Healy, B.7
Chapman, R.8
Welzel, A.T.9
Price, R.W.10
Moore, B.11
Rangachari, V.12
Cusack, B.13
Eriksen, J.14
Jansen-West, K.15
Verbeeck, C.16
Yager, D.17
Eckman, C.18
Ye, W.19
Sagi, S.20
Cottrell, B.A.21
Torpey, J.22
Rosenberry, T.L.23
Fauq, A.24
Wolfe, M.S.25
Schmidt, B.26
Walsh, D.M.27
Koo, E.H.28
Golde, T.E.29
more..
-
55
-
-
81155154306
-
Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid β peptide length: Support for a sequential model of γ-secretase intramembrane proteolysis and regulation by the amyloid β precursor protein (APP) juxtamembrane region
-
Kukar TL, Ladd TB, Robertson P, Pintchovski SA, Moore B, Bann MA, Ren Z, Jansen-West K, Malphrus K, Eggert S, Maruyama H, Cottrell BA, Das P, Basi GS, Koo EH, Golde TE (2011) Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid β peptide length: Support for a sequential model of γ-secretase intramembrane proteolysis and regulation by the amyloid β precursor protein (APP) juxtamembrane region. J Biol Chem 286, 39804-39812.
-
(2011)
J Biol Chem
, vol.286
, pp. 39804-39812
-
-
Kukar, T.L.1
Ladd, T.B.2
Robertson, P.3
Pintchovski, S.A.4
Moore, B.5
Bann, M.A.6
Ren, Z.7
Jansen-West, K.8
Malphrus, K.9
Eggert, S.10
Maruyama, H.11
Cottrell, B.A.12
Das, P.13
Basi, G.S.14
Koo, E.H.15
Golde, T.E.16
-
56
-
-
7044254509
-
42 and change presenilin 1 conformation
-
DOI 10.1038/nm1112
-
Lleó A, Berezovska O, Herl L, Raju S, Deng A, Bacskai BJ, Frosch MP, Irizarry M, Hyman BT (2004) Nonsteroidal antiinflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nat Med 10, 1065-1066. (Pubitemid 39424866)
-
(2004)
Nature Medicine
, vol.10
, Issue.10
, pp. 1065-1066
-
-
Lleo, A.1
Berezovska, O.2
Herl, L.3
Raju, S.4
Deng, A.5
Bacskai, B.J.6
Frosch, M.P.7
Irizarry, M.8
Hyman, B.T.9
-
57
-
-
33947597857
-
GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42
-
DOI 10.1038/sj.emboj.7601616, PII 7601616
-
Munter LM, Voigt P, Harmeier A, Kaden D, Gottschalk KE, Weise C, Pipkorn R, Schaefer M, Langosch D, Multhaup G (2007) GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. EMBO J 26, 1702-1712. (Pubitemid 46480941)
-
(2007)
EMBO Journal
, vol.26
, Issue.6
, pp. 1702-1712
-
-
Munter, L.-M.1
Voigt, P.2
Harmeier, A.3
Kaden, D.4
Gottschalk, K.E.5
Weise, C.6
Pipkorn, R.7
Schaefer, M.8
Langosch, D.9
Multhaup, G.10
-
58
-
-
43149088724
-
Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs
-
Erratum in: J Biol Chem 283, 12680
-
Kienlen-Campard P, Tasiaux B, Van Hees J, Li M, Huysseune S, Sato T, Fei JZ, Aimoto S, Courtoy PJ, Smith SO, Constantinescu SN, Octave JN (2008) Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs. J Biol Chem 283, 7733-7744. Erratum in: J Biol Chem 283, 12680.
-
(2008)
J Biol Chem
, vol.283
, pp. 7733-7744
-
-
Kienlen-Campard, P.1
Tasiaux, B.2
Van Hees, J.3
Li, M.4
Huysseune, S.5
Sato, T.6
Fei, J.Z.7
Aimoto, S.8
Courtoy, P.J.9
Smith, S.O.10
Constantinescu, S.N.11
Octave, J.N.12
-
59
-
-
81155154304
-
Substrate sequence influences γ-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein
-
Sagi SA, Lessard CB, Winden KD, Maruyama H, Koo JC, Weggen S, Kukar TL, Golde TE, Koo EH (2011) Substrate sequence influences γ-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein. J Biol Chem 286, 39794-39803.
-
(2011)
J Biol Chem
, vol.286
, pp. 39794-39803
-
-
Sagi, S.A.1
Lessard, C.B.2
Winden, K.D.3
Maruyama, H.4
Koo, J.C.5
Weggen, S.6
Kukar, T.L.7
Golde, T.E.8
Koo, E.H.9
-
60
-
-
78649675852
-
Mutation analysis of the presenilin 1 N-terminal domain reveals a broad spectrum of gamma-secretase activity toward amyloid precursor protein and other substrates
-
Gong P, Vetrivel KS, Nguyen PD, Meckler X, Cheng H, Kounnas MZ, Wagner SL, Parent AT, Thinakaran G (2010) Mutation analysis of the presenilin 1 N-terminal domain reveals a broad spectrum of gamma-secretase activity toward amyloid precursor protein and other substrates. J Biol Chem 285, 38042-38052.
-
(2010)
J Biol Chem
, vol.285
, pp. 38042-38052
-
-
Gong, P.1
Vetrivel, K.S.2
Nguyen, P.D.3
Meckler, X.4
Cheng, H.5
Kounnas, M.Z.6
Wagner, S.L.7
Parent, A.T.8
Thinakaran, G.9
-
61
-
-
84864471159
-
Amutation in APP protects against Alzheimer's disease and age-related cognitive decline
-
Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, BehrensTW,MagnussonOT,Kong A, Thorsteinsdottir U,Watts RJ, StefanssonK(2012)Amutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99.
-
(2012)
Nature
, vol.488
, pp. 96-99
-
-
Jonsson, T.1
Atwal, J.K.2
Steinberg, S.3
Snaedal, J.4
Jonsson, P.V.5
Bjornsson, S.6
Stefansson, H.7
Sulem, P.8
Gudbjartsson, D.9
Maloney, J.10
Hoyte, K.11
Gustafson, A.12
Liu, Y.13
Lu, Y.14
Bhangale, T.15
Graham, R.R.16
Huttenlocher, J.17
Bjornsdottir, G.18
Andreassen, O.A.19
Jönsson, E.G.20
Palotie, A.21
Behrens, T.W.22
Magnusson, O.T.23
Kong, A.24
Thorsteinsdottir, U.25
Watts, R.J.26
Stefansson, K.27
more..
-
62
-
-
79953318386
-
The intranasal administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP): A newrodent model to test palliative and neuroprotective agents for Parkinson's disease
-
Prediger RD, Aguiar AS Jr, Moreira EL, Matheus FC, Castro AA, Walz R, De Bem AF, Latini A, Tasca CI, Farina M, Raisman-Vozari R (2011) The intranasal administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP): A newrodent model to test palliative and neuroprotective agents for Parkinson's disease. Curr Pharm Des 17, 489-507.
-
(2011)
Curr Pharm des
, vol.17
, pp. 489-507
-
-
Prediger, R.D.1
Aguiar Jr., A.S.2
Moreira, E.L.3
Matheus, F.C.4
Castro, A.A.5
Walz, R.6
De Bem, A.F.7
Latini, A.8
Tasca, C.I.9
Farina, M.10
Raisman-Vozari, R.11
-
63
-
-
77955402231
-
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future
-
Fox SH, Brotchie JM (2010) The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. Prog Brain Res 184, 133-157.
-
(2010)
Prog Brain Res
, vol.184
, pp. 133-157
-
-
Fox, S.H.1
Brotchie, J.M.2
|